Endocrine Society Annual Meeting

“Today, hernia is really an endocrine disease,” according to Hong Zhao.

Shanlee Davis, MD, University of Colorado, Children’s Hospital Colorado, and team were interested in the effects of this pre-pubertal androgen treatment on the testicular function, or puberty.

Farid Saad, DVM, PhD, Bayer Pharma AG learned that the men with type 1 diabetes did experience benefits of long-term testosterone therapy – they showed improvements in their underlying diseases.

Researchers are always looking for new ways to use existing medications. That is true for the hormone oxytocin, which a group of researchers recently looked at as a potential weight loss tool for men.

Many male patients with low to moderate levels of testosterone are being diagnosed with depression more often these days. The question then for healthcare professionals becomes how best to treat them.

Childhood can be a stressful enough time without the impact of outside influences and other factors. Healthcare professionals around the country are working to ensure that young gender dysphoria patients get the care and help they need in their process.

Researchers reported no association between endogenous testosterone and incident stroke and ischemic changes in men evaluated via brain MRI imaging.

Due to allergy concerns and changing dietary habits, children (particularly adolescents) are consuming fewer nuts. Some researchers are concerned that the lack of this key food could contribute to other health issues later in life.

Testosterone is not significantly associated with bone mineral density or fracture risk. Estrone, however, may have a role in bone health and fracture prevention in postmenopausal women.

Study results show improvements in body composition, intrahepatic lipids, and cardiovascular risk markers in obese men treated with growth hormone for six months compared with placebo.

According to a recent retrospective study, orlistat is not associated with hepatotoxic effects after one year of use and it contributes to weight loss in obese patients.

Phase III studies show LDMP to be safe and effective for treatment of vasomotor symptoms in menopausal women.